We are live on
!
Find out more
WA
WestEnd Advisors Portfolio holdings
AUM
$4.14B
1-Year Est. Return
15.99%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+15.99%
3 Year Est. Return
+49.16%
5 Year Est. Return
+46.23%
10 Year Est. Return
+187.39%
AUM
$3.68B
AUM Growth
-$3.32T
(-100%)
Cap. Flow
+$3.64B
Cap. Flow
% of AUM
99.06%
Top 10 Holdings %
Top 10 Hldgs %
66.15%
Holding
387
New
387
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$433M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$329M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$254M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$238M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$235M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 7.27% |
| 2 | Consumer Discretionary | 4.37% |
| 3 | Technology | 4.27% |
| 4 | Communication Services | 3.81% |
| 5 | Healthcare | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Starbucks
SBUX
$119B
| $1.17K | ﹤0.01% |
+10
| New | +$1.13K |
|
102
Advanced Micro Devices
AMD
$821B
| $1.15K | ﹤0.01% |
+8
| New | +$1.07K |
|
103
Texas Instruments
TXN
$259B
| $1.13K | ﹤0.01% |
+6
| New | +$1.15K |
|
104
Intuitive Surgical
ISRG
$125B
| $1.08K | ﹤0.01% |
+3
| New | +$1.03K |
|
105
Bristol-Myers Squibb
BMY
$123B
| $1.06K | ﹤0.01% |
+17
| New | +$997 |
|
|
MRSH
106
Marsh
MRSH
$87.7B
| $1.04K | ﹤0.01% |
+6
| New | +$997 |
|
107
CVS Health
CVS
$137B
| $1.03K | ﹤0.01% |
+10
| New | +$924 |
|
108
Zoetis
ZTS
$31.9B
| $976 | ﹤0.01% |
+4
| New | +$876 |
|
109
Chubb
CB
$137B
| $966 | ﹤0.01% |
+5
| New | +$939 |
|
110
Oracle
ORCL
$350B
| $959 | ﹤0.01% |
+11
| New | +$1.03K |
|
111
Intercontinental Exchange
ICE
$80.1B
| $957 | ﹤0.01% |
+7
| New | +$927 |
|
112
Applied Materials
AMAT
$417B
| $944 | ﹤0.01% |
+6
| New | +$869 |
|
113
Truist Financial
TFC
$62.3B
| $936 | ﹤0.01% |
+16
| New | +$978 |
|
114
Elevance Health
ELV
$82.9B
| $927 | ﹤0.01% |
+2
| New | +$841 |
|
115
Target
TGT
$63.4B
| $925 | ﹤0.01% |
+4
| New | +$973 |
|
116
CME Group
CME
$88.6B
| $913 | ﹤0.01% |
+4
| New | +$880 |
|
117
Aon
AON
$77.5B
| $901 | ﹤0.01% |
+3
| New | +$899 |
|
118
Amgen
AMGN
$197B
| $899 | ﹤0.01% |
+4
| New | +$844 |
|
119
US Bancorp
USB
$98.4B
| $898 | ﹤0.01% |
+16
| New | +$946 |
|
120
Stryker
SYK
$122B
| $802 | ﹤0.01% |
+3
| New | +$787 |
|
121
IBM
IBM
$200B
| $801 | ﹤0.01% |
+6
| New | +$753 |
|
122
Moody's
MCO
$88.3B
| $781 | ﹤0.01% |
+2
| New | +$771 |
|
123
Moderna
MRNA
$23.6B
| $761 | ﹤0.01% |
+3
| New | +$877 |
|
124
Automatic Data Processing
ADP
$102B
| $739 | ﹤0.01% |
+3
| New | +$679 |
|
125
Gilead Sciences
GILD
$165B
| $726 | ﹤0.01% |
+10
| New | +$689 |
|
Similar funds
GCM
SP
ZP
BOK
SHCM
AP
CG
BT
WestEnd Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, WestEnd Advisors held 387 positions worth $3.68B, down 100% from $3.32T the previous quarter. Its ten largest holdings account for 66% of the portfolio.
WestEnd Advisors deployed $3.64B of net new capital in Q4 2021, opening 387 new positions. Its largest new stake was State Street Technology Select Sector SPDR ETF: 5,262,538 shares worth $457M.
By sector, the portfolio is most concentrated in Financials at 7.3% of assets, down from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
- WestEnd Advisors's largest Q4 2021 buy was State Street Technology Select Sector SPDR ETF: 5,262,538 shares worth $457M.
- WestEnd Advisors's ten largest holdings make up 66% of its $3.68B portfolio in Q4 2021.
- WestEnd Advisors opened 387 new positions and closed 0 in Q4 2021.
- WestEnd Advisors's portfolio value fell 100% quarter-over-quarter to $3.68B.
Based on WestEnd Advisors's 13F filing for Q4 2021, filed 14 Jan 2022.